ARCHIVES

Blincyto Demonstrates Response In Minimal Residual Disease ALL

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

MSKCC oncologist settles insider trading case with SEC.

November 11, 2005

NIH Revises K Series Awards; RFP Available; Program Announcement

June 9, 1995

DCT Board Sends Letter Opposing Bill Requiring Research On RU 486

November 13, 1992

Scientists Defend NCI, Criticize Post Series As Inaccurate

November 20, 1981

Cancer Advocates Use Benefit Analysis To Press For Funds

May 11, 1990

Whole Brain Radiation Raises Risk Of Memory Problems

September 26, 2008